血液脳関門技術の世界市場レポート 2025年

血液脳関門技術市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR27.8%で53億7,000万米ドルに成長します。予測期間の成長は、希少薬や希少神経疾患への注目の高まり、中枢神経系に関連する負担の増加、神経疾患の罹患率の増加や高齢者の増加、バイオマーカー探索の進歩、強固な医療インフラなどに起因しています。予測期間における主要動向としては、ナノテクノロジーの進展、研究資金の増加、中枢神経系疾患治療における成長、非侵襲的デリバリー方法に対する需要の高まり、新規ドラッグデリバリーシステムの開発、製薬企業とバイオテクノロジー企業の提携、規制当局による支援の強化などが挙げられます。

血液脳関門技術市場は、神経疾患の有病率の増加により成長が見込まれています。これらの疾患は、脳、脊髄、神経、筋肉などのさまざまなコンポーネントを含む中枢神経系と末梢神経系の両方に影響を及ぼします。神経疾患の罹患率上昇の要因としては、人口の高齢化、診断方法の改善、肥満や座りっぱなしの生活といった高リスク要因につながるライフスタイルの変化などが挙げられます。血液脳関門技術は、脳へのドラッグデリバリーを改善する上で重要な役割を果たしており、神経疾患の治療における大きな課題に対処し、これらの疾患の管理に大きな影響を与えています。例えば、パーキンソン財団は、米国におけるパーキンソン病の診断症例が急増しており、2022年12月には2021年比で9万人に達すると報告しています。この動向は、血液脳関門技術市場の成長の原動力を浮き彫りにしています。

この市場の主要企業は、脳に特化したドラッグデリバリーを強化する革新的な特許技術の開発に注力しています。これらの進歩は、脳への治療送達に関連するハードルを克服する上で大きな進歩であり、神経学におけるアンメット・メディカル・ニーズに対する有望な解決策を提供するものです。例えば、バイオアークティックABは2022年11月、米国特許商標庁（USPTO）より、血液脳関門を通過するバイオ医薬品の輸送を強化する技術に関する新たな特許を取得しました。これは、脳の自然な保護関門を迂回することで薬効を向上させることを目的とした、同社のブレイントランスポーター特許ポートフォリオの一部です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、コロナ禍、景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の血液脳関門技術 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の血液脳関門技術市場：成長率分析
• 世界の血液脳関門技術市場の実績：規模と成長、2019～2024年
• 世界の血液脳関門技術市場の予測：規模と成長、2024～2029年、2034年
• 世界の血液脳関門技術総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血液脳関門技術市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• 二重特異性抗体受容体介在性トランスサイトーシス（RMT）アプローチ
• トロイの木馬アプローチ
• 透過性の向上
• 受動拡散
• その他
• 世界の血液脳関門技術市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• アルツハイマー病
• てんかん
• パーキンソン病
• 多発性硬化症
• ハンター症候群
• 脳腫瘍
• その他
• 世界の血液脳関門技術市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 外科センター
• 研究機関
• その他
• 世界の血液脳関門技術市場、二重特異性抗体受容体介在性トランスサイトーシス（RMT）アプローチのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 二重特異性抗体
• 融合タンパク質
• 受容体標的送達システム
• 世界の血液脳関門技術市場、トロイの木馬型アプローチのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 脂質ベースのキャリア（リポソーム、ミセル）
• ペプチドベースのキャリア
• ナノ粒子を介した送達
• 世界の血液脳関門技術市場、透過性の増加のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 化学透過剤
• 物理的な破壊方法
• 透過性向上のためのナノ材料
• 世界の血液脳関門技術市場、受動拡散のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 小分子ドラッグデリバリー
• 親油性ドラッグデリバリー
• ナノキャリアベースの受動拡散
• 世界の血液脳関門技術市場、その他の技術タイプ別サブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 磁気標的ドラッグデリバリー
• 遺伝子治療とウイルスベクタ
• エクソソームベースのデリバリーシステム
• 幹細胞ベースの送達システム

第7章 地域別・国別分析

• 世界の血液脳関門技術市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の血液脳関門技術市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血液脳関門技術市場：競合情勢
• 血液脳関門技術市場：企業プロファイル
  • Pfizer Inc.
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • AbbVie Inc.

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Bristol Myers Squibb
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Bayer AG
• Biogen Inc.
• Eisai Co. Ltd.
• Alnylam Pharmaceuticals Inc.
• JCR Pharma Co. Ltd.
• Genentech Inc.
• Denali Therapeutics Inc.
• Voyager Therapeutics Inc.
• Fujifilm Cellular Dynamics Inc.
• Angiochem Inc.
• Ossianix Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 血液脳関門技術市場、2029年：新たな機会を提供する国
• 血液脳関門技術市場、2029年：新たな機会を提供するセグメント
• 血液脳関門技術市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Blood-brain barrier (BBB) technologies encompass advanced methods and innovations crafted to explore, manipulate, and traverse the blood-brain barrier. These technologies are geared towards delivering therapeutic agents to the brain while safeguarding the barrier's protective functions, thus aiding in the treatment of neurological disorders.

Key BBB technologies include the bispecific antibody receptor-mediated transcytosis (RMT) approach, the trojan horse approach, methods to increase permeability, passive diffusion, and others. The bispecific antibody receptor-mediated transcytosis (RMT) approach entails utilizing bispecific antibodies capable of binding to targets within the brain and specific receptors on the blood-brain barrier, facilitating their transport into the brain. These technologies find applications in treating conditions such as Alzheimer's disease, epilepsy, Parkinson's disease, multiple sclerosis, Hunter's syndrome, brain cancer, and more. End-users include hospitals, surgical centers, research institutes, and others.

The blood-brain barrier technologies market research report is one of a series of new reports from The Business Research Company that provides blood-brain barrier technologies market statistics, including blood-brain barrier technologies industry global market size, regional shares, competitors with a blood-brain barrier technologies market share, detailed blood-brain barrier technologies market segments, market trends and opportunities, and any further data you may need to thrive in the blood-brain barrier technologies industry. This blood-brain barrier technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood brain barrier technologies market size has grown exponentially in recent years. It will grow from $1.57 billion in 2024 to $2.01 billion in 2025 at a compound annual growth rate (CAGR) of 28.1%. The growth in the historic period can be attributed to an emphasis on patient-centric drug development, increasing the funds for research, growing awareness about the disease, increasing the prevalence of neurological diseases, and innovation of drugs and delivery devices.

The blood brain barrier technologies market size is expected to see exponential growth in the next few years. It will grow to $5.37 billion in 2029 at a compound annual growth rate (CAGR) of 27.8%. The growth in the forecast period can be attributed to increasing focus on orphan drugs and rare neurological disorders, the growing burden related to CNS, increasing incidence of neurological diseases and augmenting the geriatric population, advancements in biomarker discovery, and robust healthcare infrastructure. Major trends in the forecast period include advancements in nanotechnology, increasing research funding, growth in CNS disorder treatments, rising demand for non-invasive delivery methods, development of novel drug delivery systems, collaboration between pharmaceutical and biotech companies, and increased regulatory support.

The blood-brain barrier technologies market is poised for growth due to the increasing prevalence of neurological diseases. These diseases affect both the central and peripheral nervous systems, including various components such as the brain, spinal cord, nerves, and muscles. Factors contributing to the rising incidence of neurological diseases include an aging population, improved diagnostic methods, and lifestyle changes leading to higher-risk factors such as obesity and sedentary lifestyles. Blood-brain barrier technology plays a crucial role in improving drug delivery to the brain, addressing a major challenge in treating neurological disorders and significantly impacting the management of these diseases. For example, the Parkinson's Foundation reported a steep 50% increase in diagnosed cases of Parkinson's disease in the U.S., reaching 90,000 people in December 2022, compared to 2021. This trend underscores the driving force behind the growth of the blood-brain barrier technologies market.

Leading companies in this market are concentrating on developing innovative, patented technologies to enhance drug delivery specifically to the brain. These advancements represent significant progress in overcoming the hurdles associated with delivering therapeutics to the brain, offering promising solutions for unmet medical needs in neurology. For instance, BioArctic AB was granted a new patent by the US Patent and Trademark Office (USPTO) in November 2022 for technology that enhances the transport of biopharmaceuticals across the blood-brain barrier, part of their Brain Transporter patent portfolio aimed at improving drug effectiveness by bypassing the brain's natural protective barrier.

In October 2024, AbbVie, a U.S.-based biopharmaceutical company, acquired J&J-backed Aliada Therapeutics for $1.4 billion. This acquisition allows AbbVie to expand its neuroscience portfolio by leveraging Aliada's blood-brain barrier (BBB) technology to improve drug delivery for Alzheimer's and other central nervous system (CNS) diseases. Aliada Therapeutics is a U.S.-based biotechnology company specializing in blood-brain barrier technology.

Major companies operating in the blood brain barrier technologies market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Bayer AG, Biogen Inc., Eisai Co. Ltd., Alnylam Pharmaceuticals Inc., JCR Pharma Co. Ltd., Genentech Inc., Denali Therapeutics Inc., Voyager Therapeutics Inc., Fujifilm Cellular Dynamics Inc., Angiochem Inc., Ossianix Inc., ArmaGen Inc., BiOasis Technologies Inc., BioArctic AB

North America was the largest region in the blood brain barrier technologies market in 2024. The regions covered in the blood brain barrier technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood brain barrier technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood brain barrier technologies market consists of revenues earned by entities by providing services such as drug delivery systems and permeability testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood brain barrier technologies market also includes sales of microfluidic devices, biomarkers, chemical permeabilizers, and receptor-mediated transport enhancers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Brain Barrier Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood brain barrier technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood brain barrier technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood brain barrier technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: Bispecific Antibody Receptor-Mediated Transcytosis (RMT) Approach; Trojan Horse Approach; Increasing Permeability; Passive Diffusion; Other Technologies
• 2) By Application: Alzheimers Disease; Epilepsy; Parkinsons Disease; Multiple Sclerosis; Hunters Syndrome; Brain Cancer; Other Applications
• 3) By End-User: Hospitals; Surgical Centers; Research Institutes; Other End-Users
• Subsegments:
• 1) By Bispecific Antibody Receptor-Mediated Transcytosis (RMT) Approach: Bispecific Antibodies; Fusion Proteins; Receptor-Targeted Delivery Systems
• 2) By Trojan Horse Approach: Lipid-Based Carriers (Liposomes, Micelles); Peptide-Based Carriers; Nanoparticle-Mediated Delivery
• 3) By Increasing Permeability: Chemical Permeabilizers; Physical Disruption Methods; Nanomaterials For Permeability Enhancement
• 4) By Passive Diffusion: Small Molecule Drug Delivery; Lipophilic Drug Delivery; Nanocarrier-Based Passive Diffusion
• 5) By Other Technologies: Magnetically Targeted Drug Delivery; Gene Therapy And Viral Vectors; Exosome-Based Delivery Systems; Stem Cell-Based Delivery Systems
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Brain Barrier Technologies market Characteristics

3. Blood Brain Barrier Technologies market Trends And Strategies

4. Blood Brain Barrier Technologies market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Blood Brain Barrier Technologies Growth Analysis And Strategic Analysis Framework

• 5.1. Global Blood Brain Barrier Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Blood Brain Barrier Technologies market Growth Rate Analysis
• 5.4. Global Blood Brain Barrier Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Blood Brain Barrier Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Blood Brain Barrier Technologies Total Addressable Market (TAM)

6. Blood Brain Barrier Technologies market Segmentation

• 6.1. Global Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bispecific Antibody Receptor-Mediated Transcytosis (RMT) Approach
• Trojan Horse Approach
• Increasing Permeability
• Passive Diffusion
• Other Technologies
• 6.2. Global Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alzheimer's Disease
• Epilepsy
• Parkinson's Disease
• Multiple Sclerosis
• Hunter's Syndrome
• Brain Cancer
• Other Applications
• 6.3. Global Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Surgical Centers
• Research Institutes
• Other End-Users
• 6.4. Global Blood Brain Barrier Technologies Market, Sub-Segmentation Of Bispecific Antibody Receptor-Mediated Transcytosis (RMT) Approach, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bispecific Antibodies
• Fusion Proteins
• Receptor-Targeted Delivery Systems
• 6.5. Global Blood Brain Barrier Technologies Market, Sub-Segmentation Of Trojan Horse Approach, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lipid-Based Carriers (Liposomes, Micelles)
• Peptide-Based Carriers
• Nanoparticle-Mediated Delivery
• 6.6. Global Blood Brain Barrier Technologies Market, Sub-Segmentation Of Increasing Permeability, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemical Permeabilizers
• Physical Disruption Methods
• Nanomaterials For Permeability Enhancement
• 6.7. Global Blood Brain Barrier Technologies Market, Sub-Segmentation Of Passive Diffusion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Molecule Drug Delivery
• Lipophilic Drug Delivery
• Nanocarrier-Based Passive Diffusion
• 6.8. Global Blood Brain Barrier Technologies Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Magnetically Targeted Drug Delivery
• Gene Therapy And Viral Vectors
• Exosome-Based Delivery Systems
• Stem Cell-Based Delivery Systems

7. Blood Brain Barrier Technologies market Regional And Country Analysis

• 7.1. Global Blood Brain Barrier Technologies market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Blood Brain Barrier Technologies market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Brain Barrier Technologies market

• 8.1. Asia-Pacific Blood Brain Barrier Technologies market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Brain Barrier Technologies market

• 9.1. China Blood Brain Barrier Technologies market Overview
• 9.2. China Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Brain Barrier Technologies market

• 10.1. India Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Brain Barrier Technologies market

• 11.1. Japan Blood Brain Barrier Technologies market Overview
• 11.2. Japan Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Brain Barrier Technologies market

• 12.1. Australia Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Brain Barrier Technologies market

• 13.1. Indonesia Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Brain Barrier Technologies market

• 14.1. South Korea Blood Brain Barrier Technologies market Overview
• 14.2. South Korea Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Brain Barrier Technologies market

• 15.1. Western Europe Blood Brain Barrier Technologies market Overview
• 15.2. Western Europe Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Brain Barrier Technologies market

• 16.1. UK Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Brain Barrier Technologies market

• 17.1. Germany Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Brain Barrier Technologies market

• 18.1. France Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Brain Barrier Technologies market

• 19.1. Italy Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Brain Barrier Technologies market

• 20.1. Spain Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Brain Barrier Technologies market

• 21.1. Eastern Europe Blood Brain Barrier Technologies market Overview
• 21.2. Eastern Europe Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Brain Barrier Technologies market

• 22.1. Russia Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Brain Barrier Technologies market

• 23.1. North America Blood Brain Barrier Technologies market Overview
• 23.2. North America Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Brain Barrier Technologies market

• 24.1. USA Blood Brain Barrier Technologies market Overview
• 24.2. USA Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Brain Barrier Technologies market

• 25.1. Canada Blood Brain Barrier Technologies market Overview
• 25.2. Canada Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Brain Barrier Technologies market

• 26.1. South America Blood Brain Barrier Technologies market Overview
• 26.2. South America Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Brain Barrier Technologies market

• 27.1. Brazil Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Brain Barrier Technologies market

• 28.1. Middle East Blood Brain Barrier Technologies market Overview
• 28.2. Middle East Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Brain Barrier Technologies market

• 29.1. Africa Blood Brain Barrier Technologies market Overview
• 29.2. Africa Blood Brain Barrier Technologies market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Blood Brain Barrier Technologies market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Blood Brain Barrier Technologies market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Brain Barrier Technologies market Competitive Landscape And Company Profiles

• 30.1. Blood Brain Barrier Technologies market Competitive Landscape
• 30.2. Blood Brain Barrier Technologies market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Blood Brain Barrier Technologies market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol Myers Squibb
• 31.3. Takeda Pharmaceutical Company Limited
• 31.4. Eli Lilly and Company
• 31.5. Bayer AG
• 31.6. Biogen Inc.
• 31.7. Eisai Co. Ltd.
• 31.8. Alnylam Pharmaceuticals Inc.
• 31.9. JCR Pharma Co. Ltd.
• 31.10. Genentech Inc.
• 31.11. Denali Therapeutics Inc.
• 31.12. Voyager Therapeutics Inc.
• 31.13. Fujifilm Cellular Dynamics Inc.
• 31.14. Angiochem Inc.
• 31.15. Ossianix Inc.

32. Global Blood Brain Barrier Technologies market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Brain Barrier Technologies market

34. Recent Developments In The Blood Brain Barrier Technologies market

35. Blood Brain Barrier Technologies market High Potential Countries, Segments and Strategies

• 35.1 Blood Brain Barrier Technologies market In 2029 - Countries Offering Most New Opportunities
• 35.2 Blood Brain Barrier Technologies market In 2029 - Segments Offering Most New Opportunities
• 35.3 Blood Brain Barrier Technologies market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer